Form 4: Ali Behbahani Reports Acquisition of 17,857 Shares of Korro Bio, Inc.

Ali Behbahani, a director and 10% owner of Korro Bio, Inc., reports acquiring 17,857 shares of common stock at $56 per share on April 22, 2024.

Summary

• On April 22, 2024, Ali Behbahani acquired 17,857 shares of Korro Bio, Inc. common stock at a price of $56 per share.
• The acquisition was made pursuant to a Subscription Agreement dated April 17, 2024.
• Following the transaction, Mr. Behbahani indirectly beneficially owns 1,090,793 shares through NEA 17 GP, LLC, NEA Partners 17, L.P., and New Enterprise Associates 17, L.P. (NEA 17).
• Mr. Behbahani disclaims beneficial ownership of the securities held by NEA 17 except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard filing related to a stock acquisition. The fact that a director is buying shares could be seen as mildly positive, but it's not a strong indicator.

Positives

• The acquisition of shares by a director and 10% owner could be seen as a positive signal about the company's prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence.

Key Dates